Saturday 23 May 2026
Main Program
Room: Burke Theatre
|
09.00-09.30 |
Registration |
|
|
|
World Oncology Day Mast Cell Tumors |
|
|
09.30-09.45 |
Introduction by Davide Berlato |
Davide Berlato |
|
09.45-10.30 |
Medical Management of Canine Mast Cell Tumors: Chemotherapy or Targeted Therapy? |
Kristen Weishaar |
|
10.30–11.00 |
Coffee break |
|
|
11.00-11.45 |
Prognostication of Mast Cell Tumors: What Pathology Can (and Cannot) Tell Us |
Ricardo Strefezzi |
|
11.45-12.30 |
The Sentinel lymph node in Mast Cell Tumors - the where, the how, the why |
Nicholas Bacon |
|
12.30-13.00 |
Panel discussion chaired by Davide Berlato |
Speaker Panel |
|
13.00-15.00 |
Lunch on your own |
|
|
|
General abstracts |
|
|
15.00-15.15 |
Prospective study of metronomic chemotherapy drug residues in cancer-bearing dogs |
Alexia Kaladjian |
|
15.15-15.30 |
Neoadjuvant recombinant feline interleukin-2 immunotherapy for dogs with localised appendicular osteosarcoma – a pilot study | Joana Gomez Fernandez |
|
15.30-15.45 |
Volumetric Modulated Arc Therapy for Total Lymphoid Irradiation in Two Dogs with Multicentric Lymphoma | Ilektra Athanasiadi |
|
15.45-16.00 |
Prognostic value of serum albumin and albumin:globulin ratio in dogs with Diffuse Large B-cell Lymphoma | José Martins |
|
16.00-16.30 |
Coffee break |
|
|
16.30-17.00 |
Sponsored talk by DeepScan
|
|
|
|
General abstracts |
|
|
17.00-17.15 |
Evaluation of the efficacy and safety of oral rimcazole in 31 dogs with advanced solid tumours |
Clare Knottenbelt |
|
17.15-17.30 |
Evaluation of serum magnesium concentration in tumor-bearing dogs receiving carboplatin: incidence and clinical relevance | Ilaria Casalino |
|
17.30-17.45 |
Sentinel lymph node mapping in canine mast cell tumours of the limbs: is preoperative mapping always necessary? A pilot study | Marzia Cino |
|
17.45-18.00 |
Neuroendocrine Heart Base Tumours in Dogs with Right-Sided Heart Failure: A Poor-Prognosis Subgroup | Pablo Delgado-Bonet |
|
18.00 |
Conference closes |
|
